Tag Archives: Receives

Spanish company OrbitalAds receives three million euro funding from the European Commission under the Horizon2020 program

For the first time in the history of the H2020 program, the EC enters as a partner in a group of European companies through the Framework Program born with the aim of supporting startups in the European Union with the potential to become ‘unicorns’ Madrid, December 10, 2019 – OrbitalAds, the Spanish company that has… Read More »

GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above

Print this page London UK, Philadelphia USA April 26, 2019 — GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of Benlysta (belimumab), a B-lymphocyte stimulator (BLyS)-specific inhibitor, in children with lupus from as young as five years of age. Dr… Read More »